HAVCR2 and melanoma: For instance, in vitro blockade with anti-TIM-3 mAbs improves the cytotoxicity, production of IFN-γ, and proliferation of NK cells from melanoma patients [164] and the cytotoxicity of lung cancer patient NK cells [163].